Company intelligence / Profile preview

Biosigma

Ownership: Private
Employees: ~66
Development stage: Commercial

Overview

Biosigma is a leading Italian manufacturer of disposable plastic items and in vitro diagnostic devices for biotechnology research, clinical chemistry labs, and the pharmaceutical sector. The company’s products are CE-marked for IVD use and manufactured under ISO 13485 quality standards. Their portfolio includes a wide range of laboratory consumables as well as immunochromatographic rapid tests for infectious diseases. They have implemented advanced sustainability initiatives including biobased plastics and plastic neutrality projects.

Therapeutic areas: Infectious Diseases
Modalities: Device (laboratory plasticware and in vitro diagnostic devices)Immunochromatographic rapid test
Industry: Protein Biomarker Diagnostics

Partnerships

Ogyre (plastic neutrality project)Dominique Dutscher Group distribution network

Beyond the preview

Go deeper on Biosigma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biosigma.

Explore the full profile